Catalyst Wire Dossier Catalyst Wire Dossier

RECLIPSEN 28 DAY

Desogestrel and Ethinyl Estradiol · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for RECLIPSEN 28 DAY, covering 2013-01-31 to 2022-04-29. Get the full timeline:

Most recent: FDA Approved: RECLIPSEN 28 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing